In conclusion, this research group was the first to establish a novel axis of SNHG14/miR-186/ATG14 in CRC cells which could be pivotal in regulating CRC development and cisplatin resistance in CRC cells and tissues [264]. The gene discussed is ATG14; the disease is colorectal carcinoma.